[1] PASCALE R, GIANNELLA M, BARTOLETTI M, et al.Use of Meropenem in Treating Carbapenem-Resistant Enterobacteriaceae Infections[J]. Expert Review of Anti-Infective Therapy, 2019, 17(10): 819-827. [2] TAMMA PD, HEIL EL, JUSTO JA, et al.Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections[J]. Clinical Infectious Diseases, 2024, ciae403: 1-56. [3] WU XQ, YAN HL, ZHENG PC, et al.Adverse Drug Reaction of Central Nervous System Induced by Meropenem: a Case Report and Literature Analysis[J]. China Pharmaceuticals(中国药业), 2022, 31(20): 116-121. [4] ESCHENAUERR GA.Antifungal Therapies for Aspergillus spp.: Present and Future[J]. Seminars in Respiratory and Critical Care Medicine, 2024, 45(1): 61-68. [5] JOHN J, LOO A, MAZUR S, et al.Therapeutic Drug Monitoring of Systemic Antifungal Agents: a Pragmatic Approach for Adult and Pediatric Patients[J]. Expert Opinion on Drug Metabolism & Toxicology, 2019, 15(11): 881-895. [6] MCCREARY EK, DAVIS MR, NARAYANAN N, et al.Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium[J]. Pharmacotherapy, 2023, 43(10): 1043-1050. [7] HU JJ, ZHANG EF.Literature Analysis of 97 Cases of Voriconazole Adverse Reactions[J]. Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志), 2023, 29(2): 224-227. [8] HUANG DN, XU HB, QIU ZC.Analysis of Clinical Pharmacists Participating in Treatment of One Patient Suspected with Drug-Induced Mental Disorders in ICU[J]. China Modern Medicine(中国当代医药), 2014, 21(3): 162-164. [9] TSENG YJ, TAI CH, CHEN GY, et al.Navigating Pharmacokinetic and Pharmacodynamics Challenges of β-lactam Antibiotics in Patients with Low Body Weight: Efficacy, Toxicity, and Dosage Optimi-zation[J]. Therapeutic Advances in Drug Safety, 2025, 16: 1-12. [10] NEO HY, TAN KT, CAROLINE C, et al.Higher Rates of Carbapenem-related Seizures in Older Hospitalized Adults[J]. Internal Medicine Journal, 2020, 50(1): 123-127. [11] NORRBY SR.Neurotoxicity of Carbapenem Antibacterials[J]. Drug Safety, 1996, 15(2): 87-90. [12] PASCUAL A, CALANDRA T, BOLAY S, et al.Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes[J]. Clinical Infectious Diseases, 2008, 46(2): 201-211. [13] HU L, HUANG Q, HUANG S, et al.Therapeutic Drug Monitoring of Voriconazole and CYP2C19 Phenotype for Dose Optimization in Paediatric Patients[J]. European Journal of Clinical Pharmacology, 2023, 79(9): 1271-1278. [14] RESZTAK M, ZALEWSKA P, WACHOWIAK J, et al.Voriconazole Therapeutic Drug Monitoring Including Analysis of CYP2C19 Phenotype in Immunocompromised Pediatric Patients with Invasive Fungal Infections[J]. European Journal of Clinical Pharmacology, 2024, 80(11): 1829-1840. [15] MESINI A, LOY A, LOSURDO G, et al.Uncommon Occurrence of High Piperacillin-Tazobactam and Meropenem Plasma Concentrations and Concomitant Absence of Neurotoxicity in Pediatrics[J]. Minerva Anestesiologica, 2018, 84(9): 1111-1112. [16] ZHANG XJ, YANG HX, GUO XB, et al.Adverse Reactions of Visual Disturbances and Hallucinations Induced by Voriconazole Tablets in Two Cases and Related Literature Review[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(6): 588-591. [17] YE QX, ZHENG DF, JI LT.Report of Three Cases of Mental Disorders Caused by Voriconazole[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2024, 17(36): 166-169. [18] CHEN FC.Analysis of One Case of Central Adverse Reaction Caused by Meropenem[J]. Electronic Journal of Clinical Medical Literature(临床医药文献电子杂志), 2019, 6(40): 180. [19] BANGERT MK, HASBUN R.Neurological and Psychiatric Adverse Effects of Antimicrobials[J]. CNS Drugs, 2019, 33(8): 727-753. [20] YANG L, WANG C, ZHANG Y, et al.Central Nervous System Toxicity of Voriconazole: Risk Factors and Threshold-a Retrospective Cohort Study[J]. Infection and Drug Resistance, 2022, 15: 7475-7484. [21] LEVEQUE J, MERVEILLEUS C, TIBERGHIEN M.Systematic Review of Neuropsychiatric Toxicity in Second Generation Antifungals with an Illustrative Case Report[J]. Journal of the Academy of Consultation-Liaison Psychiatry, 2025, 66(3): 230-240. [22] XIAO J, LI HY, GUO DH, et al.Active Monitoring Study of Central Nervous System Adverse Drug Reactions due to Commonly Used Carbapenems[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2024, 40(17): 2562-2566. [23] CHENG L, LIANG ZM, LIU ZR, et al.Clinical Characteristics of Voriconazole-Induced Neurological ADR and the Occurrence of Hypokalemia and Hyponatremia[J]. China Pharmacy(中国药房), 2021, 32(20): 2520-2524. |